(Q39509984)

12 September 2017

title

Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity (English)

1 reference

12 September 2017

0 references

1 reference

Gelber AC

1

1 reference

12 September 2017

Wigley FM

2

1 reference

12 September 2017

Stallings RY

3

1 reference

12 September 2017

Bone LR

4

1 reference

12 September 2017

Barker AV

5

1 reference

12 September 2017

Baylor I

6

1 reference

12 September 2017

Harris CW

7

1 reference

12 September 2017

Hill MN

8

1 reference

12 September 2017

Zeger SL

9

1 reference

12 September 2017

Levine DM

10

1 reference

12 September 2017

publication date

1 May 1999

1 reference

Journal of Clinical Epidemiology

12 September 2017

published in

1 reference

12 September 2017

volume

52

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

441-446

1 reference

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Prevalence of symptoms of Raynaud's phenomenon in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Raynaud's phenomenon in a female population: prevalence and association with other conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Prevalence of Raynaud phenomenon in Tartu and Tartumaa, southern Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Prevalence of Raynaud's phenomenon in Japanese males and females

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Prevalence of Raynaud phenomenon in the adult population of South Carolina.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

The epidemiology of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Racial differences in scleroderma among women in Michigan

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Understanding the disparities in morbidity and mortality among racial and ethnic groups in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Community-academic health center partnerships for underserved minority populations. One solution to a national crisis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Narrowing the gap in health status of minority populations: a community-academic medical center partnership

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Enhancing the role of community-health workers in research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

The community health worker. A resource for improved health care delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Raynaud's phenomenon as side effect of beta-blockers in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Epidemiology of Systemic Sclerosis (Scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Familial clustering of end-stage renal disease in blacks with lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900015-3

7 January 2021

10.1016/S0895-4356(99)00015-3

Identifiers

DOI

1 reference

release_t77idhuolfdr3n5sme4ng5wc7m

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t77idhuolfdr3n5sme4ng5wc7m

24 November 2022

mapped directly with Wikidata item

1 reference